Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Review article: therapeutic aspects of bile acid signalling in the gut‐liver axis
Benedikt Simbrunner, Michael Trauner, Thomas Reiberger
Alimentary Pharmacology & Therapeutics (2021) Vol. 54, Iss. 10, pp. 1243-1262
Open Access | Times Cited: 69

Showing 51-75 of 69 citing articles:

Gut microbiota disorder induces liver dysfunction in polycystic ovary syndrome rats' model by regulating metabolite rosmarinic acid
Tingting Zhang, Huimin Gao, Yali Fan, et al.
Life Sciences (2023) Vol. 330, pp. 121912-121912
Closed Access | Times Cited: 3
Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection
Natthaya Chuaypen, Thananya Jinato, Anchalee Avihingsanon, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Traditional Chinese Medicine formula Dai-Zong-Fang alleviating hepatic steatosis in db/db mice via gut microbiota modulation
Liwei Zhang, Li Zhu, Xiaoyun Zhu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Risk factors for esophagogastric variceal-related poor outcomes in primary biliary cholangitis: A prospective cohort study
Lin Han, Huan Xie, Xuemei Ma, et al.
iLiver (2024) Vol. 3, Iss. 1, pp. 100081-100081
Open Access
Impact of Drug-Mediated Inhibition of Intestinal Transporters on Nutrient and Endogenous Substrate Disposition…an Afterthought?
Kshitee Kharve, Andrew S. Engley, Mary F. Paine, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 447-447
Open Access
Efficacy of Shu-yi-ning-chang decoction on IBS-D: Modulating Nr4a3 pathway to reduce visceral hypersensitivity
Yajing Guo, Qiongqiong Lu, Xiao-Jun Yang, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0299376-e0299376
Open Access
The Synergistic Trio of Metabolic Master Regulators Sustaining a Vicious Circle of Pathological Processes in Post-Traumatic Stress Disorder
М. V. Kondashevskaya, К. А. Artemyeva, Л.М. Михалева
Journal of Evolutionary Biochemistry and Physiology (2024) Vol. 60, Iss. 3, pp. 988-1002
Open Access
Gut Microbiota Dysbiosis in the Pathogenesis of Metabolic-dysfunction Associated Steatotic Liver Disease (MASLD)
Gh Jeelani Mir, Nissar Ul Ashraf
The International Journal of Gastroenterology and Hepatology Diseases (2024) Vol. 03
Closed Access
Metabolic-associated fatty liver disease and pregnancy complications: new challenges and clinical perspectives
Yang Zhang, Yifan Bu, Rui Zhao, et al.
Therapeutic Advances in Endocrinology and Metabolism (2024) Vol. 15
Open Access
Synergic Trio of Metabolic Regulators Supporting the Vicious Circle of Pathological Processes in Post-Traumatic Stress Disorder
М. V. Kondashevskaya, К. А. Artemyeva, Л.М. Михалева
Российский физиологический журнал им  И  М  Сеченова (2024) Vol. 110, Iss. 5, pp. 704-722
Closed Access
Pathogenic entero- and salivatypes harbour changes in microbiome virulence and antimicrobial resistance genes with increasing chronic liver disease severity
Sunjae Lee, Bethlehem Arefaine, Neelu Begum, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
The Effect of Duck Bile Acid Extract on the Fecal Microbiota, Short Chain Fatty Acids, Fat Digestibility and Blood Biochemical Indices in Cats
Bing Han, Peng Zhao, Shukun Liang, et al.
Applied Sciences (2023) Vol. 13, Iss. 17, pp. 9713-9713
Open Access | Times Cited: 1
Impact of elobixibat on liver tumors, microbiome, and bile acid levels in a mouse model of nonalcoholic steatohepatitis
Yoshiaki Sugiyama, Kenta Yamamoto, Takashi Honda, et al.
Hepatology International (2023) Vol. 17, Iss. 6, pp. 1378-1392
Open Access | Times Cited: 1
Pathogenetic bases of the combined use of drugs from the groups of hepatoprotectors and phytosorbents
Yu.N. Alekhin, V. S. Ponamarev, O. S. Popova
International Journal of Veterinary Medicine (2022), Iss. 2, pp. 47-52
Open Access | Times Cited: 2
Author's reply: The relationship between systemic inflammation and liver fibrogenesis in patients with cirrhosis
Benedikt Simbrunner, Thomas Reiberger, Mattias Mandorfer
Liver International (2022) Vol. 43, Iss. 2, pp. 520-521
Closed Access | Times Cited: 1
Impact of Elobixibat on Liver Tumors, Microbiome and Bile Acid Levels in a Mouse Model of Nonalcoholic Steatohepatitis
Yoshiaki Sugiyama, Kenta Yamamoto, Takashi Honda, et al.
Research Square (Research Square) (2023)
Open Access
The Effect of MSTN Mutation on Bile Acid Metabolism and Lipid Metabolism in Cattle
Di Wu, Song Wang, Chao Hai, et al.
Metabolites (2023) Vol. 13, Iss. 7, pp. 836-836
Open Access
A Message from the Editors
Colin W. Howden, Rohit Loomba
Alimentary Pharmacology & Therapeutics (2022) Vol. 57, Iss. 1, pp. 4-5
Closed Access
Lifestyle and Genetic Modifiers of Liver Disease Progression
Mattias Mandorfer, Annalisa Berzigotti
Springer eBooks (2022), pp. 29-41
Closed Access
Previous Page - Page 3

Scroll to top